These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 10479056)

  • 1. HLA-G inhibits the allogeneic proliferative response.
    Riteau B; Menier C; Khalil-Daher I; Sedlik C; Dausset J; Rouas-Freiss N; Carosella ED
    J Reprod Immunol; 1999 Jul; 43(2):203-11. PubMed ID: 10479056
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular and immunologic aspects of the nonclassical HLA class I antigen HLA-G: evidence for an important role in the maternal tolerance of the fetal allograft.
    Moreau P; Paul P; Rouas-Freiss N; Kirszenbaum M; Dausset J; Carosella ED
    Am J Reprod Immunol; 1998 Sep; 40(3):136-44. PubMed ID: 9764357
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The alpha1 domain of HLA-G1 and HLA-G2 inhibits cytotoxicity induced by natural killer cells: is HLA-G the public ligand for natural killer cell inhibitory receptors?
    Rouas-Freiss N; Marchal RE; Kirszenbaum M; Dausset J; Carosella ED
    Proc Natl Acad Sci U S A; 1997 May; 94(10):5249-54. PubMed ID: 9144223
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The immunotolerance role of HLA-G.
    Rouas-Freiss N; Khalil-Daher I; Riteau B; Menier C; Paul P; Dausset J; Carosella ED
    Semin Cancer Biol; 1999 Feb; 9(1):3-12. PubMed ID: 10092545
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Fetomaternal tolerance: role of HLA-G molecule in the protection of the fetus against maternal natural killer activity].
    Rouas-Freiss N; Kirszenbaum M; Dausset J; Carosella ED
    C R Acad Sci III; 1997 May; 320(5):385-92. PubMed ID: 9239324
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of HLA-G versus HLA-E on NK function: HLA-G is able to inhibit NK cytolysis by itself.
    Khalil-Daher I; Riteau B; Menier C; Sedlik C; Paul P; Dausset J; Carosella ED; Rouas-Freiss N
    J Reprod Immunol; 1999 Jul; 43(2):175-82. PubMed ID: 10479053
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HLA-G inhibits the transendothelial migration of human NK cells.
    Dorling A; Monk NJ; Lechler RI
    Eur J Immunol; 2000 Feb; 30(2):586-93. PubMed ID: 10671215
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Soluble HLA-G molecule. An alternatively spliced HLA-G mRNA form candidate to encode it in peripheral blood mononuclear cells and human trophoblasts.
    Moreau P; Carosella E; Teyssier M; Prost S; Gluckman E; Dausset J; Kirszenbaum M
    Hum Immunol; 1995 Jul; 43(3):231-6. PubMed ID: 7558941
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HLA-G promotes immune tolerance.
    Rouas-Freiss N; Paul P; Dausset J; Carosella ED
    J Biol Regul Homeost Agents; 2000; 14(2):93-8. PubMed ID: 10841284
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HLA-G1-transfected K562 cells do not inhibit NK-cell-mediated lysis in europium release cytotoxicity assay.
    Sapak M; Buc M
    Bratisl Lek Listy; 2003; 104(10):300-4. PubMed ID: 15055728
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Induction of tolerogenic dendritic cells by membrane-bound HLA-G in vitro].
    Zhou H; Li WM; Zhang M; Liu ZR; Zou P
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2007 Apr; 15(2):369-72. PubMed ID: 17493349
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HLA-G suppresses proliferation of CD4(+) T-lymphocytes.
    Bainbridge DR; Ellis SA; Sargent IL
    J Reprod Immunol; 2000 Aug; 48(1):17-26. PubMed ID: 10996380
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HLA-G has a concentration-dependent effect on the generation of an allo-CTL response.
    Kapasi K; Albert SE; Yie S; Zavazava N; Librach CL
    Immunology; 2000 Oct; 101(2):191-200. PubMed ID: 11012772
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HLA-G in organ transplantation: towards clinical applications.
    Deschaseaux F; Delgado D; Pistoia V; Giuliani M; Morandi F; Durrbach A
    Cell Mol Life Sci; 2011 Feb; 68(3):397-404. PubMed ID: 21103908
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [HLA-G: from feto-maternal tolerance to organ grafting].
    Carosella ED
    Bull Mem Acad R Med Belg; 2009; 164(3-4):87-99; discussion 99-101. PubMed ID: 20120086
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peptide presentation and NK inhibition by HLA-G.
    Münz C; Stevanović S; Rammensee HG
    J Reprod Immunol; 1999 Jul; 43(2):139-55. PubMed ID: 10479050
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HLA-G2, -G3, and -G4 isoforms expressed as nonmature cell surface glycoproteins inhibit NK and antigen-specific CTL cytolysis.
    Riteau B; Rouas-Freiss N; Menier C; Paul P; Dausset J; Carosella ED
    J Immunol; 2001 Apr; 166(8):5018-26. PubMed ID: 11290782
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HLA-G1 co-expression boosts the HLA class I-mediated NK lysis inhibition.
    Riteau B; Menier C; Khalil-Daher I; Martinozzi S; Pla M; Dausset J; Carosella ED; Rouas-Freiss N
    Int Immunol; 2001 Feb; 13(2):193-201. PubMed ID: 11157852
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Direct evidence to support the role of HLA-G in protecting the fetus from maternal uterine natural killer cytolysis.
    Rouas-Freiss N; Gonçalves RM; Menier C; Dausset J; Carosella ED
    Proc Natl Acad Sci U S A; 1997 Oct; 94(21):11520-5. PubMed ID: 9326642
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Indoleamine 2,3 dioxygenase and human leucocyte antigen-G inhibit the T-cell alloproliferative response through two independent pathways.
    Le Rond S; Gonzalez A; Gonzalez AS; Carosella ED; Rouas-Freiss N
    Immunology; 2005 Nov; 116(3):297-307. PubMed ID: 16236119
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.